Yu et al. showed that treatment of mammary tumor-bearing mice with TDEs lead to the accumulation of myeloid precursors cells in the spleen and inhibition of their differentiation into DCs by promoting the transcription of interleukin-6 (IL-6) [129]. Here, IL6 is linked to breast cancer.